- Filed
- Jun 23, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Jun 23, 2025 | 5.91M sh |
| Shares Diluted | Q3 2025 · Apr 30, 2025 | 5.35M sh |
| Shares Diluted | Q3 2025 · Apr 30, 2025 | 5.35M sh |
| Shares Diluted | Q3 2025 · Apr 30, 2024 | 5.35M sh |
| Shares Diluted | Q3 2025 · Apr 30, 2024 | 5.35M sh |
| Operating Cash Flow | Q3 2025 · Apr 30, 2025 | −$118.33K |
| Operating Cash Flow | Q3 2025 · Apr 30, 2024 | −$9.87K |
| Cash And Equivalents | Q3 2025 · Apr 30, 2025 | $9.94K |
| Stockholders Equity | Q3 2025 · Apr 30, 2025 | −$181.32K |
| Stockholders Equity | Q3 2025 · Jan 31, 2025 | −$67.24K |
| Stockholders Equity | Q3 2025 · Oct 31, 2024 | −$48.01K |
| Stockholders Equity | Q3 2025 · Jul 31, 2024 | −$23.39K |
| Stockholders Equity | Q3 2025 · Apr 30, 2024 | −$22.22K |
| Stockholders Equity | Q3 2025 · Jan 31, 2024 | −$9.27K |
| Stockholders Equity | Q3 2025 · Oct 31, 2023 | −$16.44K |
| Stockholders Equity | Q3 2025 · Jul 31, 2023 | $1.15K |
| Current Liabilities | Q3 2025 · Apr 30, 2025 | $289.03K |
| Current Liabilities | Q3 2025 · Jul 31, 2024 | $125K |
| Total Liabilities | Q3 2025 · Apr 30, 2025 | $289.03K |
| Total Liabilities | Q3 2025 · Jul 31, 2024 | $125K |
| Current Assets | Q3 2025 · Apr 30, 2025 | $46.44K |
| Current Assets | Q3 2025 · Jul 31, 2024 | $39.2K |
| Total Assets | Q3 2025 · Apr 30, 2025 | $107.71K |
| Total Assets | Q3 2025 · Jul 31, 2024 | $101.61K |
| Eps Diluted | Q3 2025 · Apr 30, 2025 | −$0.34 |
| Eps Diluted | Q3 2025 · Apr 30, 2025 | −$0.35 |
| Eps Diluted | Q3 2025 · Apr 30, 2024 | $0.00 |
| Eps Diluted | Q3 2025 · Apr 30, 2024 | $0.00 |
| Eps Basic | Q3 2025 · Apr 30, 2025 | −$0.34 |
| Eps Basic | Q3 2025 · Apr 30, 2025 | −$0.35 |
| Eps Basic | Q3 2025 · Apr 30, 2024 | $0.00 |
| Eps Basic | Q3 2025 · Apr 30, 2024 | $0.00 |
| Sga Expense | Q3 2025 · Apr 30, 2025 | $1.82M |
| Sga Expense | Q3 2025 · Apr 30, 2025 | $1.86M |
| Sga Expense | Q3 2025 · Apr 30, 2024 | $3.25K |
| Sga Expense restated | Q3 2025 · Apr 30, 2024 | $15.97K |
| Net Income | Q3 2025 · Apr 30, 2025 | −$1.83M |
| Net Income | Q3 2025 · Apr 30, 2025 | −$1.87M |
| Net Income | Q3 2025 · Apr 30, 2024 | −$12.95K |
| Net Income | Q3 2025 · Apr 30, 2024 | −$23.37K |
| Operating Income | Q3 2025 · Apr 30, 2025 | −$1.83M |
| Operating Income | Q3 2025 · Apr 30, 2025 | −$1.87M |
| Operating Income | Q3 2025 · Apr 30, 2024 | −$12.95K |
| Operating Income | Q3 2025 · Apr 30, 2024 | −$23.37K |
| Revenue | Q3 2025 · Apr 30, 2025 | $23K |
| Revenue | Q3 2025 · Apr 30, 2024 | $21.7K |
| Capex | Q3 2025 · Apr 30, 2024 | $20K |